[ITCI] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
25-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -9.99%
YoY- -49.57%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 131,506 87,433 25,516 12,404 61 0 5 444.91%
PBT -28,131 -44,026 -85,734 -60,689 -40,583 -40,748 -31,267 -1.74%
Tax 448 -6,772 -541 10 -1,125 5,266 -1,058 -
NP -28,579 -37,254 -85,734 -60,699 -40,583 -40,748 -30,209 -0.91%
Tax Rate - - - - - - - -
Total Cost 160,085 124,687 111,250 73,103 40,643 40,748 30,214 32.01%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -21.73 -42.61 -336.00 -489.36 -66,954.04 0.00 -597,600.63 -81.78%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.30 -0.39 -1.05 -0.76 -0.73 -0.74 -0.56 -9.87%
EPS Diluted -0.30 -0.39 -1.05 -0.76 -0.73 -0.74 -0.56 -9.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.